Startup profile · funding coverage
Allara funding, valuation and investors
Insurance-covered virtual care platform for hormonal, metabolic and reproductive health.
Keep track of Allara
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Venture financing
$30 million · October 13, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$30M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, New York, United States
Investors in latest funding
Other: Index Ventures , GV , Camino Partners , Foreground Capital , Family Fund
Overview
New York-based Allara coordinates women's health clinicians and registered dietitians in a virtual care model spanning hormonal, metabolic and reproductive conditions.
Why Allara is interesting
Allara combines insurance reimbursement, longitudinal specialty care and a large patient dataset, while positioning AI as clinician capacity infrastructure rather than a replacement for physicians.
Product & use cases
Allara provides virtual medical care, nutrition support, prescriptions, laboratory testing and personalized treatment plans. It is developing provider-facing AI for information synthesis and decision support and patient-facing AI between visits.
- Virtual hormonal and metabolic care
- PCOS and reproductive health
- Nutrition and medication management
- AI-assisted clinical workflows
Key facts
- $30 million financing brought total funding to $75 million.
- More than 120,000 women served, according to the company.
- Stage and valuation were not disclosed.
Funding history (newest first)
Investors in our directory
Funds linked from Allara's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: The integrated clinician-and-dietitian model addresses overlapping hormonal, metabolic and reproductive conditions within one longitudinal relationship and is distributed through insurance coverage.
Allara competes with virtual women's health platforms, general telehealth providers and specialty clinics. Its key tests are clinical outcomes, payer economics, patient retention and whether AI improves capacity without weakening physician oversight.
-
Maven Clinic direct
Large virtual women's and family health platform.
-
Midi Health direct
Virtual specialty care platform focused on midlife women.
-
Tia direct
Hybrid primary and women's health provider.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Allara's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.